참고문헌
- Abbas, T., and Dutta, A. (2009). p21 in cancer: intricate networks and multiple activities. Nat. Rev. Cancer 9, 400-414. https://doi.org/10.1038/nrc2657
- Abraham, R.T. (2001). Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev. 15, 2177-2196. https://doi.org/10.1101/gad.914401
- Ahn, B.H., Kim, H.S., Song, S., Lee, I.H., Liu, J., Vassilopoulos, A., Deng, C.X. and Finkel, T. (2008). A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis. Proc. Natl. Acad. Sci. USA 105, 14447-14452. https://doi.org/10.1073/pnas.0803790105
- Ahuja, N., Schwer, B., Carobbio, S., Waltregny, D., North, B.J., Castronovo, V., Maechler, P. and Verdin, E. (2007). Regulation of insulin secretion by SIRT4, a mitochondrial ADPribosyltransferase. J. Biol. Chem. 282, 33583-33592. https://doi.org/10.1074/jbc.M705488200
- Alexander, A., and Walker, C.L. (2011). The role of LKB1 and AMPK in cellular responses to stress and damage. FEBS Lett. 585, 952-957. https://doi.org/10.1016/j.febslet.2011.03.010
- Alhazzazi, T.Y., Kamarajan, P., Joo, N., Huang, J.Y., Verdin, E., D'Silva, N.J., and Kapila, Y.L. (2011). Sirtuin-3 (SIRT3)., a novel potential therapeutic target for oral cancer. Cancer 117, 1670-1678. https://doi.org/10.1002/cncr.25676
- Anderson, K.A., and Hirschey, M.D. (2012). Mitochondrial protein acetylation regulates metabolism. Essays Biochem. 52, 23-35. https://doi.org/10.1042/bse0520023
- Barber, M.F., Michishita-Kioi, E., Xi, Y., Tasselli, L., Kioi, M., Moqtaderi, Z., Tennen, R.I., Paredes, S., Young, N.L., Chen, K., et al. (2012). SIRT7 links H3K18 deacetylation to maintenance of oncogenic transformation. Nature 487, 114-118.
- Bauer, I., Grozio, A., Lasiglie, D., Basile, G., Sturla, L., Magnone, M., Sociali, G., Soncini, D., Caffa, I., Poggi, A., et al. (2012). The NAD+-dependent histone deacetylase SIRT6 promotes cytokine production and migration in pancreatic cancer cells by regulating Ca2+ responses. J. Biol. Chem. 287, 40924-40937. https://doi.org/10.1074/jbc.M112.405837
- Bell, E.L., and Guarente, L. (2011). The SirT3 divining rod points to oxidative stress. Mol. Cell 42, 561-568. https://doi.org/10.1016/j.molcel.2011.05.008
- Bell, E.L., Emerling, B.M., Ricoult, S.J., and Guarente, L. (2011). SirT3 suppresses hypoxia inducible factor 1alpha and tumor growth by inhibiting mitochondrial ROS production. Oncogene 30, 2986-2996. https://doi.org/10.1038/onc.2011.37
- Bordone, L., Motta, M.C., Picard, F., Robinson, A., Jhala, U.S., Apfeld, J., McDonagh, T., Lemieux, M., McBurney, M., Szilvasi, A., et al. (2006). Sirt1 regulates insulin secretion by repressing UCP2 in pancreatic beta cells. PLoS Biol. 4, e31.
- Bradbury, C.A., Khanim, F.L., Hayden, R., Bunce, C.M., White, D.A., Drayson, M.T., Craddock, C., and Turner, B.M. (2005). Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors. Leukemia 19, 1751-1759. https://doi.org/10.1038/sj.leu.2403910
-
Canto, C., Gerhart-Hines, Z., Feige, J.N., Lagouge, M., Noriega, L., Milne, J.C., Elliott, P.J., Puigserver, P., and Auwerx, J. (2009). AMPK regulates energy expenditure by modulating
$NAD^+$ metabolism and SIRT1 activity. Nature 458, 1056-1060. https://doi.org/10.1038/nature07813 - Chen, J., Chan, A.W., To, K.F., Chen, W., Zhang, Z., Ren, J., Song, C., Cheung, Y.S., Lai, P.B., Cheng, S.H., et al. (2013). SIRT2 overexpression in hepatocellular carcinoma mediates epithelial to mesenchymal transition by protein kinase B/glycogen synthase kinase-3beta/beta-catenin signaling. Hepatology 57, 2287-2298. https://doi.org/10.1002/hep.26278
- Ciccia, A., and Elledge, S.J. (2010). The DNA damage response: making it safe to play with knives. Mol. Cell 40, 179-204. https://doi.org/10.1016/j.molcel.2010.09.019
- Cosentino, C., Grieco, D., and Costanzo, V. (2011). ATM activates the pentose phosphate pathway promoting anti-oxidant defence and DNA repair. EMBO J. 30, 546-555. https://doi.org/10.1038/emboj.2010.330
- Csibi, A., Fendt, S.M., Li, C., Poulogiannis, G., Choo, A.Y., Chapski, D.J., Jeong, S.M., Dempsey, J.M., Parkhitko, A., Morrison, T., et al. (2013). The mTORC1 pathway stimulates glutamine metabolism and cell proliferation by repressing SIRT4. Cell 153, 840-854. https://doi.org/10.1016/j.cell.2013.04.023
- Currie, E., Schulze, A., Zechner, R., Walther, T.C., and Farese, R.V., Jr. (2013). Cellular fatty acid metabolism and cancer. Cell Metabol. 18, 153-161. https://doi.org/10.1016/j.cmet.2013.05.017
- Dan, L., Klimenkova, O., Klimiankou, M., Klusman, J.H., van den Heuvel-Eibrink, M.M., Reinhardt, D., Welte, K., and Skokowa, J. (2012). The role of sirtuin 2 activation by nicotinamide phosphoribosyltransferase in the aberrant proliferation and survival of myeloid leukemia cells. Haematologica 97, 551-559. https://doi.org/10.3324/haematol.2011.055236
- Dang, C.V. (2010). Rethinking the Warburg effect with Myc micromanaging glutamine metabolism. Cancer Res. 70, 859-862. https://doi.org/10.1158/0008-5472.CAN-09-3556
- DeBerardinis, R.J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., and Thompson, C.B. (2007). Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc. Natl. Acad. Sci. USA 104, 19345-19350. https://doi.org/10.1073/pnas.0709747104
- Deng, C.X. (2006). BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution. Nucleic Acids Res. 34, 1416-1426. https://doi.org/10.1093/nar/gkl010
- Dominy, J.E., Jr., Lee, Y., Jedrychowski, M.P., Chim, H., Jurczak, M.J., Camporez, J.P., Ruan, H.B., Feldman, J., Pierce, K., Mostoslavsky, R., et al. (2012). The deacetylase Sirt6 activates the acetyltransferase GCN5 and suppresses hepatic gluconeogenesis. Mol. Cell 48, 900-913. https://doi.org/10.1016/j.molcel.2012.09.030
- Dryden, S.C., Nahhas, F.A., Nowak, J.E., Goustin, A.S., and Tainsky, M.A. (2003). Role for human SIRT2 NAD-dependent deacetylase activity in control of mitotic exit in the cell cycle. Mol. Cell. Biol. 23, 3173-3185. https://doi.org/10.1128/MCB.23.9.3173-3185.2003
- Du, J., Zhou, Y., Su, X., Yu, J.J., Khan, S., Jiang, H., Kim, J., Woo, J., Kim, J.H., Choi, B.H., et al. (2011). Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase. Science 334, 806-809. https://doi.org/10.1126/science.1207861
- Eng, C.H., Yu, K., Lucas, J., White, E., and Abraham, R.T. (2010). Ammonia derived from glutaminolysis is a diffusible regulator of autophagy. Sci. Signal. 3, ra31.
- Fan, W., and Luo, J. (2010). SIRT1 regulates UV-induced DNA repair through deacetylating XPA. Mol. Cell 39, 247-258. https://doi.org/10.1016/j.molcel.2010.07.006
- Finkel, T., Deng, C.X., and Mostoslavsky, R. (2009). Recent progress in the biology and physiology of sirtuins. Nature 460, 587-591. https://doi.org/10.1038/nature08197
- Finley, L.W., Carracedo, A., Lee, J., Souza, A., Egia, A., Zhang, J., Teruya-Feldstein, J., Moreira, P.I., Cardoso, S.M., Clish, C.B., et al. (2011). SIRT3 opposes reprogramming of cancer cell metabolism through HIF1alpha destabilization. Cancer Cell 19, 416-428. https://doi.org/10.1016/j.ccr.2011.02.014
- Ford, E., Voit, R., Liszt, G., Magin, C., Grummt, I., and Guarente, L. (2006). Mammalian Sir2 homolog SIRT7 is an activator of RNA polymerase I transcription. Genes Dev. 20, 1075-1080. https://doi.org/10.1101/gad.1399706
- Frescas, D., Valenti, L., and Accili, D. (2005). Nuclear trapping of the forkhead transcription factor FoxO1 via Sirt-dependent deacetylation promotes expression of glucogenetic genes. J. Biol. Chem. 280, 20589-20595. https://doi.org/10.1074/jbc.M412357200
- Fu, X., Wan, S., Lyu, Y.L., Liu, L.F., and Qi, H. (2008). Etoposide induces ATM-dependent mitochondrial biogenesis through AMPK activation. PLoS One 3, e2009. https://doi.org/10.1371/journal.pone.0002009
- Gatenby, R.A., and Gillies, R.J. (2004). Why do cancers have high aerobic glycolysis? Nat. Rev. Cancer 4, 891-899. https://doi.org/10.1038/nrc1478
- Gerhart-Hines, Z., Rodgers, J.T., Bare, O., Lerin, C., Kim, S.H., Mostoslavsky, R., Alt, F.W., Wu, Z., and Puigserver, P. (2007). Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1alpha. EMBO J. 26, 1913-1923. https://doi.org/10.1038/sj.emboj.7601633
- Guarente, L. (2013). Calorie restriction and sirtuins revisited. Genes Dev. 27, 2072-2085. https://doi.org/10.1101/gad.227439.113
- Guarente, L., and Kenyon, C. (2000). Genetic pathways that regulate ageing in model organisms. Nature 408, 255-262. https://doi.org/10.1038/35041700
- Haigis, M.C., and Guarente, L.P. (2006). Mammalian sirtuins--emerging roles in physiology, aging, and calorie restriction. Genes Dev. 20, 2913-2921. https://doi.org/10.1101/gad.1467506
- Haigis, M.C., and Sinclair, D.A. (2010). Mammalian sirtuins: biological insights and disease relevance. Ann. Rev. Pathol. 5, 253-295. https://doi.org/10.1146/annurev.pathol.4.110807.092250
- Haigis, M.C., Mostoslavsky, R., Haigis, K.M., Fahie, K., Christodoulou, D.C., Murphy, A.J., Valenzuela, D.M., Yancopoulos, G.D., Karow, M., Blander, G., et al. (2006). SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic beta cells. Cell 126, 941-954. https://doi.org/10.1016/j.cell.2006.06.057
- Hallows, W.C., Yu, W., Smith, B.C., Devries, M.K., Ellinger, J.J., Someya, S., Shortreed, M.R., Prolla, T., Markley, J.L., Smith, L.M., et al. (2011). Sirt3 promotes the urea cycle and fatty acid oxidation during dietary restriction. Mol. Cell 41, 139-149. https://doi.org/10.1016/j.molcel.2011.01.002
- Hallows, W.C., Yu, W., and Denu, J.M. (2012). Regulation of glycolytic enzyme phosphoglycerate mutase-1 by Sirt1 proteinmediated deacetylation. J. Biol. Chem. 287, 3850-3858. https://doi.org/10.1074/jbc.M111.317404
- Hanahan, D., and Weinberg, R.A. (2011). Hallmarks of cancer: the next generation. Cell 144, 646-674. https://doi.org/10.1016/j.cell.2011.02.013
- Hebert, A.S., Dittenhafer-Reed, K.E., Yu, W., Bailey, D.J., Selen, E.S., Boersma, M.D., Carson, J.J., Tonelli, M., Balloon, A.J., Higbee, A.J., et al. (2013). Calorie restriction and SIRT3 trigger global reprogramming of the mitochondrial protein acetylome. Mol. Cell 49, 186-199. https://doi.org/10.1016/j.molcel.2012.10.024
- Herranz, D., Maraver, A., Canamero, M., Gomez-Lopez, G., Inglada-Perez, L., Robledo, M., Castelblanco, E., Matias-Guiu, X., and Serrano, M. (2013). SIRT1 promotes thyroid carcinogenesis driven by PTEN deficiency. Oncogene 32, 4052-4056. https://doi.org/10.1038/onc.2012.407
- Hirschey, M.D., Shimazu, T., Goetzman, E., Jing, E., Schwer, B., Lombard, D.B., Grueter, C.A., Harris, C., Biddinger, S., Ilkayeva, O.R., et al. (2010). SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature 464, 121-125. https://doi.org/10.1038/nature08778
- Hou, H., Chen, W., Zhao, L., Zuo, Q., Zhang, G., Zhang, X., Wang, H., Gong, H., Li, X., Wang, M., et al. (2012). Cortactin is associated with tumour progression and poor prognosis in prostate cancer and SIRT2 other than HADC6 may work as facilitator in situ. J. Clin. Pathol. 65, 1088-1096. https://doi.org/10.1136/jclinpath-2012-200940
- Houtkooper, R.H., Pirinen, E., and Auwerx, J. (2012). Sirtuins as regulators of metabolism and healthspan. Nat. Rev. Mol. Cell Biol. 13, 225-238. https://doi.org/10.1038/nrn3209
- Hubbi, M.E., Hu, H., Kshitiz, Gilkes, D.M., and Semenza, G.L. (2013). Sirtuin-7 inhibits the activity of hypoxia-inducible factors. J. Biol. Chem. 288, 20768-20775. https://doi.org/10.1074/jbc.M113.476903
- Huffman, D.M., Grizzle, W.E., Bamman, M.M., Kim, J.S., Eltoum, I.A., Elgavish, A., and Nagy, T.R. (2007). SIRT1 is significantly elevated in mouse and human prostate cancer. Cancer Res. 67, 6612-6618. https://doi.org/10.1158/0008-5472.CAN-07-0085
- Jeong, J., Juhn, K., Lee, H., Kim, S.H., Min, B.H., Lee, K.M., Cho, M.H., Park, G.H., and Lee, K.H. (2007). SIRT1 promotes DNA repair activity and deacetylation of Ku70. Exp. Mol. Med. 39, 8-13. https://doi.org/10.1038/emm.2007.2
- Jeong, S.M., Xiao, C., Finley, L.W., Lahusen, T., Souza, A.L., Pierce, K., Li, Y.H., Wang, X., Laurent, G., German, N.J., et al. (2013). SIRT4 has tumor-suppressive activity and regulates the cellular metabolic response to DNA damage by inhibiting mitochondrial glutamine metabolism. Cancer Cell 23, 450-463. https://doi.org/10.1016/j.ccr.2013.02.024
- Jeong, S.M., Lee, A., Lee, J., and Haigis, M.C. (2014). SIRT4 protein suppresses tumor formation in genetic models of Mycinduced B cell lymphoma. J. Biol. Chem. 289, 4135-4144. https://doi.org/10.1074/jbc.M113.525949
- Jeong, S.M., Lee, J., Finley, L.W., Schmidt, P.J., Fleming, M.D., and Haigis, M.C. (2015). SIRT3 regulates cellular iron metabolism and cancer growth by repressing iron regulatory protein 1. Oncogene 34, 2115-2124. https://doi.org/10.1038/onc.2014.124
- Jiang, W., Wang, S., Xiao, M., Lin, Y., Zhou, L., Lei, Q., Xiong, Y., Guan, K.L., and Zhao, S. (2011). Acetylation regulates gluconeogenesis by promoting PEPCK1 degradation via recruiting the UBR5 ubiquitin ligase. Mol. Cell 43, 33-44. https://doi.org/10.1016/j.molcel.2011.04.028
- Jing, E., Gesta, S., and Kahn, C.R. (2007). SIRT2 regulates adipocyte differentiation through FoxO1 acetylation/deacetylation. Cell Metabol. 6, 105-114. https://doi.org/10.1016/j.cmet.2007.07.003
- Kaidi, A., Weinert, B.T., Choudhary, C., and Jackson, S.P. (2010). Human SIRT6 promotes DNA end resection through CtIP deacetylation. Science 329, 1348-1353. https://doi.org/10.1126/science.1192049
- Kanfi, Y., Peshti, V., Gil, R., Naiman, S., Nahum, L., Levin, E., Kronfeld-Schor, N., and Cohen, H.Y. (2010). SIRT6 protects against pathological damage caused by diet-induced obesity. Aging Cell 9, 162-173. https://doi.org/10.1111/j.1474-9726.2009.00544.x
- Khongkow, M., Olmos, Y., Gong, C., Gomes, A.R., Monteiro, L.J., Yague, E., Cavaco, T.B., Khongkow, P., Man, E.P., Laohasinnarong, S., et al. (2013). SIRT6 modulates paclitaxel and epirubicin resistance and survival in breast cancer. Carcinogenesis 34, 1476-1486. https://doi.org/10.1093/carcin/bgt098
- Kim, H.S., Patel, K., Muldoon-Jacobs, K., Bisht, K.S., Aykin-Burns, N., Pennington, J.D., van der Meer, R., Nguyen, P., Savage, J., Owens, K.M., et al. (2010a). SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress. Cancer Cell 17, 41-52. https://doi.org/10.1016/j.ccr.2009.11.023
- Kim, H.S., Xiao, C., Wang, R.H., Lahusen, T., Xu, X., Vassilopoulos, A., Vazquez-Ortiz, G., Jeong, W.I., Park, O., Ki, S.H., et al. (2010b). Hepatic-specific disruption of SIRT6 in mice results in fatty liver formation due to enhanced glycolysis and triglyceride synthesis. Cell Metabol. 12, 224-236. https://doi.org/10.1016/j.cmet.2010.06.009
- Kim, H.S., Vassilopoulos, A., Wang, R.H., Lahusen, T., Xiao, Z., Xu, X., Li, C., Veenstra, T.D., Li, B., Yu, H., et al. (2011). SIRT2 maintains genome integrity and suppresses tumorigenesis through regulating APC/C activity. Cancer Cell 20, 487-499. https://doi.org/10.1016/j.ccr.2011.09.004
- Kim, J.K., Noh, J.H., Jung, K.H., Eun, J.W., Bae, H.J., Kim, M.G., Chang, Y.G., Shen, Q., Park, W.S., Lee, J.Y., et al. (2013). Sirtuin7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors MiR-125a-5p and MiR-125b. Hepatology 57, 1055-1067. https://doi.org/10.1002/hep.26101
- Kiran, S., Oddi, V., and Ramakrishna, G. (2015). Sirtuin 7 promotes cellular survival following genomic stress by attenuation of DNA damage, SAPK activation and p53 response. Exp. Cell Res. 331, 123-141. https://doi.org/10.1016/j.yexcr.2014.11.001
- Krishnan, J., Danzer, C., Simka, T., Ukropec, J., Walter, K.M., Kumpf, S., Mirtschink, P., Ukropcova, B., Gasperikova, D., Pedrazzini, T., et al. (2012). Dietary obesity-associated Hif1alpha activation in adipocytes restricts fatty acid oxidation and energy expenditure via suppression of the Sirt2-NAD+ system. Genes Dev. 26, 259-270. https://doi.org/10.1101/gad.180406.111
- Lan, F., Cacicedo, J.M., Ruderman, N., and Ido, Y. (2008). SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1. Possible role in AMP-activated protein kinase activation. J. Biol. Chem. 283, 27628-27635. https://doi.org/10.1074/jbc.M805711200
- Lapenna, S., and Giordano, A. (2009). Cell cycle kinases as therapeutic targets for cancer. Nat. Rev. Drug Discov. 8, 547-566. https://doi.org/10.1038/nrd2907
- Laurent, G., German, N.J., Saha, A.K., de Boer, V.C., Davies, M., Koves, T.R., Dephoure, N., Fischer, F., Boanca, G., Vaitheesvaran, B., et al. (2013). SIRT4 coordinates the balance between lipid synthesis and catabolism by repressing malonyl CoA decarboxylase. Mol. Cell 50, 686-698. https://doi.org/10.1016/j.molcel.2013.05.012
- Li, X., Zhang, S., Blander, G., Tse, J.G., Krieger, M. and Guarente, L. (2007). SIRT1 deacetylates and positively regulates the nuclear receptor LXR. Mol. Cell 28, 91-106. https://doi.org/10.1016/j.molcel.2007.07.032
- Li, K., Casta, A., Wang, R., Lozada, E., Fan, W., Kane, S., Ge, Q., Gu, W., Orren, D., and Luo, J. (2008). Regulation of WRN protein cellular localization and enzymatic activities by SIRT1-mediated deacetylation. J. Biol. Chem. 283, 7590-7598. https://doi.org/10.1074/jbc.M709707200
- Li, S., Banck, M., Mujtaba, S., Zhou, M.M., Sugrue, M.M., and Walsh, M.J. (2010). p53-induced growth arrest is regulated by the mitochondrial SirT3 deacetylase. PLoS One 5, e10486. https://doi.org/10.1371/journal.pone.0010486
- Lim, C.S. (2006). SIRT1: tumor promoter or tumor suppressor? Med. Hypotheses 67, 341-344. https://doi.org/10.1016/j.mehy.2006.01.050
- Lim, J.H., Lee, Y.M., Chun, Y.S., Chen, J., Kim, J.E., and Park, J.W. (2010). Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1alpha. Mol. Cell 38, 864-878. https://doi.org/10.1016/j.molcel.2010.05.023
- Lin, Y.H., Yuan, J., Pei, H., Liu, T., Ann, D.K., and Lou, Z. (2015). KAP1 deacetylation by SIRT1 promotes non-homologous endjoining repair. PLoS One 10, e0123935. https://doi.org/10.1371/journal.pone.0123935
- Liszt, G., Ford, E., Kurtev, M., and Guarente, L. (2005). Mouse Sir2 homolog SIRT6 is a nuclear ADP-ribosyltransferase. J. Biol. Chem. 280, 21313-21320. https://doi.org/10.1074/jbc.M413296200
- Liu, P.Y., Xu, N., Malyukova, A., Scarlett, C.J., Sun, Y.T., Zhang, X.D., Ling, D., Su, S.P., Nelson, C., Chang, D.K., et al. (2013). The histone deacetylase SIRT2 stabilizes Myc oncoproteins. Cell Death Differ. 20, 503-514. https://doi.org/10.1038/cdd.2012.147
- Liu, T., Lin, Y.H., Leng, W., Jung, S.Y., Zhang, H., Deng, M., Evans, D., Li, Y., Luo, K., Qin, B., et al. (2014). A divergent role of the SIRT1-TopBP1 axis in regulating metabolic checkpoint and DNA damage checkpoint. Mol. Cell 56, 681-695. https://doi.org/10.1016/j.molcel.2014.10.007
- Lombard, D.B., Schwer, B., Alt, F.W., and Mostoslavsky, R. (2008). SIRT6 in DNA repair, metabolism and ageing. J. Int. Med. 263, 128-141. https://doi.org/10.1111/j.1365-2796.2007.01902.x
- Mao, Z., Hine, C., Tian, X., Van Meter, M., Au, M., Vaidya, A., Seluanov, A., and Gorbunova, V. (2011). SIRT6 promotes DNA repair under stress by activating PARP1. Science 332, 1443-1446. https://doi.org/10.1126/science.1202723
- Martinez-Pastor, B., and Mostoslavsky, R. (2012). Sirtuins, metabolism, and cancer. Front. Pharmacol. 3, 22.
- Mathias, R.A., Greco, T.M., Oberstein, A., Budayeva, H.G., Chakrabarti, R., Rowland, E.A., Kang, Y., Shenk, T., and Cristea, I.M. (2014). Sirtuin 4 is a lipoamidase regulating pyruvate dehydrogenase complex activity. Cell 159, 1615-1625. https://doi.org/10.1016/j.cell.2014.11.046
- McCord, R.A., Michishita, E., Hong, T., Berber, E., Boxer, L.D., Kusumoto, R., Guan, S., Shi, X., Gozani, O., Burlingame, A.L., et al. (2009). SIRT6 stabilizes DNA-dependent protein kinase at chromatin for DNA double-strand break repair. Aging 1, 109-121. https://doi.org/10.18632/aging.100011
- Michishita, E., McCord, R.A., Berber, E., Kioi, M., Padilla-Nash, H., Damian, M., Cheung, P., Kusumoto, R., Kawahara, T.L., Barrett, J.C., et al. (2008). SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin. Nature 452, 492-496. https://doi.org/10.1038/nature06736
- Ming, M., Shea, C.R., Guo, X., Li, X., Soltani, K., Han, W., and He, Y.Y. (2010). Regulation of global genome nucleotide excision repair by SIRT1 through xeroderma pigmentosum C. Proc. Natl. Acad. Sci. USA 107, 22623-22628. https://doi.org/10.1073/pnas.1010377108
- Morris, B.J. (2013). Seven sirtuins for seven deadly diseases of aging. Free Radical Biol. Med. 56, 133-171. https://doi.org/10.1016/j.freeradbiomed.2012.10.525
- Mostoslavsky, R., Chua, K.F., Lombard, D.B., Pang, W.W., Fischer, M.R., Gellon, L., Liu, P., Mostoslavsky, G., Franco, S., Murphy, M.M., et al. (2006). Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. Cell 124, 315-329. https://doi.org/10.1016/j.cell.2005.11.044
- Moynihan, K.A., Grimm, A.A., Plueger, M.M., Bernal-Mizrachi, E., Ford, E., Cras-Meneur, C., Permutt, M.A., and Imai, S. (2005). Increased dosage of mammalian Sir2 in pancreatic beta cells enhances glucose-stimulated insulin secretion in mice. Cell Metabol. 2, 105-117. https://doi.org/10.1016/j.cmet.2005.07.001
- Nakagawa, T., Lomb, D.J., Haigis, M.C., and Guarente, L. (2009). SIRT5 Deacetylates carbamoyl phosphate synthetase 1 and regulates the urea cycle. Cell 137, 560-570. https://doi.org/10.1016/j.cell.2009.02.026
- Negrini, S., Gorgoulis, V.G., and Halazonetis, T.D. (2010). Genomic instability--an evolving hallmark of cancer. Nat. Rev. Mol. Cell Biol. 11, 220-228. https://doi.org/10.1038/nrm2858
- North, B.J., and Verdin, E. (2007). Mitotic regulation of SIRT2 by cyclin-dependent kinase 1-dependent phosphorylation. J. Biol. Chem. 282, 19546-19555. https://doi.org/10.1074/jbc.M702990200
- Oberdoerffer, P., Michan, S., McVay, M., Mostoslavsky, R., Vann, J., Park, S.K., Hartlerode, A., Stegmuller, J., Hafner, A., Loerch, P., et al. (2008). SIRT1 redistribution on chromatin promotes genomic stability but alters gene expression during aging. Cell 135, 907-918. https://doi.org/10.1016/j.cell.2008.10.025
- Palacios, J.A., Herranz, D., De Bonis, M.L., Velasco, S., Serrano, M., and Blasco, M.A. (2010). SIRT1 contributes to telomere maintenance and augments global homologous recombination. J. Cell Biol. 191, 1299-1313. https://doi.org/10.1083/jcb.201005160
- Park, J., Chen, Y., Tishkoff, D.X., Peng, C., Tan, M., Dai, L., Xie, Z., Zhang, Y., Zwaans, B.M., Skinner, M.E., et al. (2013). SIRT5-mediated lysine desuccinylation impacts diverse metabolic pathways. Mol. Cell 50, 919-930. https://doi.org/10.1016/j.molcel.2013.06.001
- Picard, F., Kurtev, M., Chung, N., Topark-Ngarm, A., Senawong, T., Machado De Oliveira, R., Leid, M., McBurney, M.W., and Guarente, L. (2004). Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature 429, 771-776. https://doi.org/10.1038/nature02583
- Polletta, L., Vernucci, E., Carnevale, I., Arcangeli, T., Rotili, D., Palmerio, S., Steegborn, C., Nowak, T., Schutkowski, M., Pellegrini, L., et al. (2015). SIRT5 regulation of ammoniainduced autophagy and mitophagy. Autophagy 11, 253-270. https://doi.org/10.1080/15548627.2015.1009778
- Ponugoti, B., Kim, D.H., Xiao, Z., Smith, Z., Miao, J., Zang, M., Wu, S.Y., Chiang, C.M., Veenstra, T.D., and Kemper, J.K. (2010). SIRT1 deacetylates and inhibits SREBP-1C activity in regulation of hepatic lipid metabolism. J. Biol. Chem. 285, 33959-33970. https://doi.org/10.1074/jbc.M110.122978
- Qiu, X., Brown, K., Hirschey, M.D., Verdin, E., and Chen, D. (2010). Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation. Cell Metabol. 12, 662-667. https://doi.org/10.1016/j.cmet.2010.11.015
- Rodgers, J.T., Lerin, C., Haas, W., Gygi, S.P., Spiegelman, B.M., and Puigserver, P. (2005). Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 434, 113-118. https://doi.org/10.1038/nature03354
- Ryu, D., Jo, Y.S., Lo Sasso, G., Stein, S., Zhang, H., Perino, A., Lee, J.U., Zeviani, M., Romand, R., Hottiger, M.O., et al. (2014). A SIRT7-dependent acetylation switch of GABPbeta1 controls mitochondrial function. Cell Metabol. 20, 856-869. https://doi.org/10.1016/j.cmet.2014.08.001
- Santos, C.R., and Schulze, A. (2012). Lipid metabolism in cancer. FEBS J. 279, 2610-2623. https://doi.org/10.1111/j.1742-4658.2012.08644.x
- Sapkota, G.P., Deak, M., Kieloch, A., Morrice, N., Goodarzi, A.A., Smythe, C., Shiloh, Y., Lees-Miller, S.P., and Alessi, D.R. (2002). Ionizing radiation induces ataxia telangiectasia mutated kinase (ATM).-mediated phosphorylation of LKB1/STK11 at Thr-366. Biochem. J. 368, 507-516. https://doi.org/10.1042/bj20021284
- Sawada, M., Sun, W., Hayes, P., Leskov, K., Boothman, D.A., and Matsuyama, S. (2003). Ku70 suppresses the apoptotic translocation of Bax to mitochondria. Nat. Cell Biol. 5, 320-329. https://doi.org/10.1038/ncb950
- Sebastian, C., Zwaans, B.M., Silberman, D.M., Gymrek, M., Goren, A., Zhong, L., Ram, O., Truelove, J., Guimaraes, A.R., Toiber, D., et al. (2012). The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism. Cell 151, 1185-1199. https://doi.org/10.1016/j.cell.2012.10.047
- Seo, K.S., Park, J.H., Heo, J.Y., Jing, K., Han, J., Min, K.N., Kim, C., Koh, G.Y., Lim, K., Kang, G.Y., et al. (2015). SIRT2 regulates tumour hypoxia response by promoting HIF-1alpha hydroxylation. Oncogene 34, 1354-1362. https://doi.org/10.1038/onc.2014.76
- Serrano, L., Martinez-Redondo, P., Marazuela-Duque, A., Vazquez, B.N., Dooley, S.J., Voigt, P., Beck, D.B., Kane-Goldsmith, N., Tong, Q., Rabanal, R.M., et al. (2013). The tumor suppressor SirT2 regulates cell cycle progression and genome stability by modulating the mitotic deposition of H4K20 methylation. Genes Dev. 27, 639-653. https://doi.org/10.1101/gad.211342.112
- Shimazu, T., Hirschey, M.D., Hua, L., Dittenhafer-Reed, K.E., Schwer, B., Lombard, D.B., Li, Y., Bunkenborg, J., Alt, F.W., Denu, J.M., et al. (2010). SIRT3 deacetylates mitochondrial 3-hydroxy-3-methylglutaryl CoA synthase 2 and regulates ketone body production. Cell Metabol. 12, 654-661. https://doi.org/10.1016/j.cmet.2010.11.003
- Shin, J., He, M., Liu, Y., Paredes, S., Villanova, L., Brown, K., Qiu, X., Nabavi, N., Mohrin, M., Wojnoonski, K., et al. (2013). SIRT7 represses Myc activity to suppress ER stress and prevent fatty liver disease. Cell Rep. 5, 654-665. https://doi.org/10.1016/j.celrep.2013.10.007
- Someya, S., Yu, W., Hallows, W.C., Xu, J., Vann, J.M., Leeuwenburgh, C., Tanokura, M., Denu, J.M. and Prolla, T.A. (2010). Sirt3 mediates reduction of oxidative damage and prevention of age-related hearing loss under caloric restriction. Cell 143, 802-812. https://doi.org/10.1016/j.cell.2010.10.002
- Su, T.T. (2006). Cellular responses to DNA damage: one signal, multiple choices. Annu. Rev. Genet. 40, 187-208. https://doi.org/10.1146/annurev.genet.40.110405.090428
- Sundaresan, N.R., Samant, S.A., Pillai, V.B., Rajamohan, S.B., and Gupta, M.P. (2008). SIRT3 is a stress-responsive deacetylase in cardiomyocytes that protects cells from stress-mediated cell death by deacetylation of Ku70. Mol. Cell. Biol. 28, 6384-6401. https://doi.org/10.1128/MCB.00426-08
- Tao, R., Coleman, M.C., Pennington, J.D., Ozden, O., Park, S.H., Jiang, H., Kim, H.S., Flynn, C.R., Hill, S., Hayes McDonald, W., et al. (2010). Sirt3-mediated deacetylation of evolutionarily conserved lysine 122 regulates MnSOD activity in response to stress. Mol. Cell 40, 893-904. https://doi.org/10.1016/j.molcel.2010.12.013
- Tennant, D.A., Duran, R.V., and Gottlieb, E. (2010). Targeting metabolic transformation for cancer therapy. Nat. Rev. Cancer 10, 267-277. https://doi.org/10.1038/nrc2817
- Tong, X., Zhao, F., and Thompson, C.B. (2009). The molecular determinants of de novo nucleotide biosynthesis in cancer cells. Curr. Opin. Genet. Dev. 19, 32-37. https://doi.org/10.1016/j.gde.2009.01.002
- Vakhrusheva, O., Braeuer, D., Liu, Z., Braun, T., and Bober, E. (2008a). Sirt7-dependent inhibition of cell growth and proliferation might be instrumental to mediate tissue integrity during aging. J. Physiol. Pharmacol. 59 Suppl 9, 201-212.
- Vakhrusheva, O., Smolka, C., Gajawada, P., Kostin, S., Boettger, T., Kubin, T., Braun, T., and Bober, E. (2008b). Sirt7 increases stress resistance of cardiomyocytes and prevents apoptosis and inflammatory cardiomyopathy in mice. Circ.Res. 102, 703-710. https://doi.org/10.1161/CIRCRESAHA.107.164558
- Vander Heiden, M.G., Cantley, L.C., and Thompson, C.B. (2009). Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324, 1029-1033. https://doi.org/10.1126/science.1160809
- Vaquero, A., Scher, M.B., Lee, D.H., Sutton, A., Cheng, H.L., Alt, F.W., Serrano, L., Sternglanz, R., and Reinberg, D. (2006). SirT2 is a histone deacetylase with preference for histone H4 Lys 16 during mitosis. Genes Dev. 20, 1256-1261. https://doi.org/10.1101/gad.1412706
- Verdin, E., Hirschey, M.D., Finley, L.W., and Haigis, M.C. (2010). Sirtuin regulation of mitochondria: energy production, apoptosis, and signaling. Trends Biochem. Sci. 35, 669-675. https://doi.org/10.1016/j.tibs.2010.07.003
- Wang, F., Nguyen, M., Qin, F.X., and Tong, Q. (2007). SIRT2 deacetylates FOXO3a in response to oxidative stress and caloric restriction. Aging Cell 6, 505-514. https://doi.org/10.1111/j.1474-9726.2007.00304.x
- Wang, R.H., Sengupta, K., Li, C., Kim, H.S., Cao, L., Xiao, C., Kim, S., Xu, X., Zheng, Y., Chilton, B., et al. (2008). Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice. Cancer Cell 14, 312-323. https://doi.org/10.1016/j.ccr.2008.09.001
- Wang, J.B., Erickson, J.W., Fuji, R., Ramachandran, S., Gao, P., Dinavahi, R., Wilson, K.F., Ambrosio, A.L., Dias, S.M., Dang, C.V., et al. (2010). Targeting mitochondrial glutaminase activity inhibits oncogenic transformation. Cancer Cell 18, 207-219. https://doi.org/10.1016/j.ccr.2010.08.009
- Warburg, O. (1956). On the origin of cancer cells. Science 123, 309-314. https://doi.org/10.1126/science.123.3191.309
- Wise, D.R., and Thompson, C.B. (2010). Glutamine addiction: a new therapeutic target in cancer. Trends Biochem. Sci. 35, 427-433. https://doi.org/10.1016/j.tibs.2010.05.003
- Yang, C., Sudderth, J., Dang, T., Bachoo, R.M., McDonald, J.G. and DeBerardinis, R.J. (2009). Glioblastoma cells require glutamate dehydrogenase to survive impairments of glucose metabolism or Akt signaling. Cancer Res. 69, 7986-7993. https://doi.org/10.1158/0008-5472.CAN-09-2266
- Yoshizawa, T., Karim, M.F., Sato, Y., Senokuchi, T., Miyata, K., Fukuda, T., Go, C., Tasaki, M., Uchimura, K., Kadomatsu, T., et al. (2014). SIRT7 controls hepatic lipid metabolism by regulating the ubiquitin-proteasome pathway. Cell Metabol. 19, 712-721. https://doi.org/10.1016/j.cmet.2014.03.006
- Yuan, H., Wang, Z., Li, L., Zhang, H., Modi, H., Horne, D., Bhatia, R., and Chen, W. (2012). Activation of stress response gene SIRT1 by BCR-ABL promotes leukemogenesis. Blood 119, 1904-1914. https://doi.org/10.1182/blood-2011-06-361691
- Zhong, L., D'Urso, A., Toiber, D., Sebastian, C., Henry, R.E., Vadysirisack, D.D., Guimaraes, A., Marinelli, B., Wikstrom, J.D., Nir, T., et al. (2010). The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alpha. Cell 140, 280-293. https://doi.org/10.1016/j.cell.2009.12.041
피인용 문헌
- Mitochondrial Sirtuins and Molecular Mechanisms of Aging vol.23, pp.4, 2017, https://doi.org/10.1016/j.molmed.2017.02.005
- Sirtuins Expression and Their Role in Retinal Diseases vol.2017, 2017, https://doi.org/10.1155/2017/3187594
- Thienopyrimidinone Based Sirtuin-2 (SIRT2)-Selective Inhibitors Bind in the Ligand Induced Selectivity Pocket vol.60, pp.5, 2017, https://doi.org/10.1021/acs.jmedchem.6b01690
- SIRT4 regulates cancer cell survival and growth after stress vol.470, pp.2, 2016, https://doi.org/10.1016/j.bbrc.2016.01.078
- Alpha-Ketoglutarate as a Molecule with Pleiotropic Activity: Well-Known and Novel Possibilities of Therapeutic Use vol.65, pp.1, 2017, https://doi.org/10.1007/s00005-016-0406-x
- Sirtuins in metabolism, DNA repair and cancer vol.35, pp.1, 2016, https://doi.org/10.1186/s13046-016-0461-5
- Lactate dehydrogenase inhibition: exploring possible applications beyond cancer treatment vol.8, pp.6, 2016, https://doi.org/10.4155/fmc.16.10
- Therapeutic role of sirtuins in neurodegenerative disease and their modulation by polyphenols vol.73, 2017, https://doi.org/10.1016/j.neubiorev.2016.11.022
- Inhibitors of Trypanosoma cruzi Sir2 related protein 1 as potential drugs against Chagas disease vol.12, pp.1, 2018, https://doi.org/10.1371/journal.pntd.0006180
- Hsp90 Stabilizes SIRT1 Orthologs in Mammalian Cells and C. elegans vol.19, pp.11, 2018, https://doi.org/10.3390/ijms19113661
- Metabolism and Epigenetic Interplay in Cancer: Regulation and Putative Therapeutic Targets vol.9, pp.1664-8021, 2018, https://doi.org/10.3389/fgene.2018.00427
- Engineering Lineage Potency and Plasticity of Stem Cells using Epigenetic Molecules vol.8, pp.1, 2018, https://doi.org/10.1038/s41598-018-34511-7
- A 5′ AMP-Activated Protein Kinase Enzyme Activator, Compound 59, Induces Autophagy and Apoptosis in Human Oral Squamous Cell Carcinoma vol.123, pp.1, 2018, https://doi.org/10.1111/bcpt.12976
- The sirtuin 1/2 inhibitor tenovin-1 induces a nonlinear apoptosis-inducing factor-dependent cell death in a p53 null Ewing’s sarcoma cell line vol.36, pp.3, 2018, https://doi.org/10.1007/s10637-017-0541-1
- Dual Tumor Suppressor and Tumor Promoter Action of Sirtuins in Determining Malignant Phenotype vol.10, pp.1663-9812, 2019, https://doi.org/10.3389/fphar.2019.00038
- The Glycolytic Switch in Tumors: How Many Players Are Involved? vol.8, pp.17, 2015, https://doi.org/10.7150/jca.21125
- The sirtuin family in cancer vol.18, pp.18, 2019, https://doi.org/10.1080/15384101.2019.1634953
- Regulation of Adaptive Immune Cells by Sirtuins vol.10, pp.None, 2015, https://doi.org/10.3389/fendo.2019.00466
- SIRT5 downregulation is associated with poor prognosis in glioblastoma vol.24, pp.4, 2015, https://doi.org/10.3233/cbm-182197
- Sirtuins and SIRT6 in Carcinogenesis and in Diet vol.20, pp.19, 2015, https://doi.org/10.3390/ijms20194945
- Sirt4: A Multifaceted Enzyme at the Crossroads of Mitochondrial Metabolism and Cancer vol.10, pp.None, 2020, https://doi.org/10.3389/fonc.2020.00474
- Expression of SIRT1, SIRT3 and SIRT6 Genes for Predicting Survival in Triple-Negative and Hormone Receptor-Positive Subtypes of Breast Cancer vol.26, pp.4, 2015, https://doi.org/10.1007/s12253-020-00873-5
- Sirtuin 1 and Sirtuin 3 in Granulosa Cell Tumors vol.22, pp.4, 2015, https://doi.org/10.3390/ijms22042047
- Elucidation of Structural Determinants Delineates the Residues Playing Key Roles in Differential Dynamics and Selective Inhibition of Sirt1-3 vol.61, pp.3, 2015, https://doi.org/10.1021/acs.jcim.0c01193
- Structure-based design, synthesis, and biological evaluation of novel piperine-resveratrol hybrids as antiproliferative agents targeting SIRT-2 vol.11, pp.41, 2015, https://doi.org/10.1039/d1ra04061h
- One Omics Approach Does Not Rule Them All: The Metabolome and the Epigenome Join Forces in Haematological Malignancies vol.5, pp.4, 2015, https://doi.org/10.3390/epigenomes5040022